Asia Pacific Pain Relief Oil Market Size to Hit USD 2.46 Million by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Asia Pacific Pain Relief Oil Market

5.1. COVID-19 Landscape: Asia Pacific Pain Relief Oil Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Asia Pacific Pain Relief Oil Market, By Product Type

8.1. Asia Pacific Pain Relief Oil Market Revenue and Volume, by Product Type

8.1.1. Herbal Pain Relief Oils

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Medicated Pain Relief Oils

8.1.2.1. Market Revenue and Volume Forecast

Chapter 9. Asia Pacific Pain Relief Oil Market, By Application

9.1. Asia Pacific Pain Relief Oil Market Revenue and Volume, by Application

9.1.1. Musculoskeletal Pain

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Neuropathic Pain

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Post-surgical Pain Relief

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Others

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Asia Pacific Pain Relief Oil Market, By Ingredient Type

10.1. Asia Pacific Pain Relief Oil Market Revenue and Volume, by Ingredient Type

10.1.1. Camphor-based Oils

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Menthol-based Oils

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Capsaicin-based Oils

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Eucalyptus-based Oils

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Diclofenac-based Oils

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Blended Oils

10.1.6.1. Market Revenue and Volume Forecast

10.1.6. Others

10.1.6.1. Market Revenue and Volume Forecast

Chapter 11. Asia Pacific Pain Relief Oil Market, By Packaging Format

11.1. Asia Pacific Pain Relief Oil Market Revenue and Volume, by Packaging Format

11.1.1. Bottles

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Roll-ons

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Spray Bottles

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Sachets/Pouches

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Others

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Asia Pacific Pain Relief Oil Market, By End User

12.1. Asia Pacific Pain Relief Oil Market Revenue and Volume, by End User

12.1.1. Household Consumers

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Professional Therapists

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Sports Professionals

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Healthcare Facilities

12.1.4.1. Market Revenue and Volume Forecast

12.1.5. Others

12.1.5.1. Market Revenue and Volume Forecast

Chapter 13. Asia Pacific Pain Relief Oil Market, By Distribution Channel

13.1. Asia Pacific Pain Relief Oil Market Revenue and Volume, by Distribution Channel

13.1.1. Pharmacies/Drug Stores

13.1.1.1. Market Revenue and Volume Forecast

13.1.2. Supermarkets/Hypermarkets

13.1.2.1. Market Revenue and Volume Forecast

13.1.3. Online Retail

13.1.3.1. Market Revenue and Volume Forecast

13.1.3. Specialty Stores

13.1.3.1. Market Revenue and Volume Forecast

13.1.3. Others

13.1.3.1. Market Revenue and Volume Forecast

Chapter 14. Asia Pacific Pain Relief Oil Market, Regional Estimates and Trend Forecast

14.3. APAC

14.3.1. Market Revenue and Volume Forecast, by Product Type

14.3.2. Market Revenue and Volume Forecast, by Application

14.3.3. Market Revenue and Volume Forecast, by Ingredient Type

14.3.4. Market Revenue and Volume Forecast, by Packaging Format

14.3.5. Market Revenue and Volume Forecast, by End User

14.3.6. Market Revenue and Volume Forecast, by Distribution Channel

Chapter 15. Company Profiles

15.1. Haw Par Corporation Ltd.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Reckitt Benckiser Group plc

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Hisamitsu Pharmaceutical Co., Inc.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Novartis AG

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. GlaxoSmithKline plc

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Reckitt Benckiser Group plc

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Amrutanjan Health Care Ltd.

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Himalaya Wellness Company

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Emami Limited

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Dabur India Ltd.

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The Asia Pacific pain relief oil market size is expected to increase from USD 1.36 million in 2024 to USD 2.46 million by 2034.

The Asia Pacific pain relief oil market is expected to grow at a compound annual growth rate (CAGR) of around 6.11% from 2025 to 2034.

The major players in the Asia Pacific pain relief oil market include Haw Par Corporation Ltd., Reckitt Benckiser Group plc, Hisamitsu Pharmaceutical Co., Inc., Novartis AG, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Amrutanjan Health Care Ltd., Himalaya Wellness Company, Emami Limited, Dabur India Ltd., Mentholatum Company, Inc., Procter & Gamble, Biofreeze, Sombra Cosmetics, Inc., Penetrex, Nature’s Bounty Co., Patanjali Ayurved Ltd., Durex BioCare Pvt. Ltd, Shree Baidyanath Ayurved Bhawan Pvt. Ltd., and Eagle Brand Medicated Oil.

The driving factors of the Asia Pacific pain relief oil market are the healthcare industry, driven by increasing demand for natural and effective pain management solutions.